Mirum Pharmaceuticals MIRM
NASDAQ MIRM
$100.90 +0.27 (+0.27%)
As of: Sep 4, 2026 · 3:59 PM EDT

Mirum Pharmaceuticals (MIRM) Gross Margin (QoQ) (2021 - 2026)

Analysis

Mirum Pharmaceuticals (MIRM) Gross Margin (QoQ) (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Mirum Pharmaceuticals 6.40 Bn 5.96 Bn 145.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 80.00
Mar 31, 2026 96.00
Dec 31, 2025 22.00
Sep 30, 2025 -87.00
Jun 30, 2025 230.00
Mar 31, 2025 229.00
Dec 31, 2024 11.00
Sep 30, 2024 295.00
Jun 30, 2024 -22.00
Mar 31, 2024 1,021.00
Dec 31, 2023 -1,454.00
Sep 30, 2023 -326.00
Jun 30, 2023 -241.00
Mar 31, 2023 35.00
Dec 31, 2022 -49.00
Sep 30, 2022 -118.00
Jun 30, 2022 437.00
Mar 31, 2022 4,184.00
Dec 31, 2021 -6,064.00
Sep 30, 2021 0.00